Trial Profile
Regorafenib Eye Drops Phase I Study in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Wet age-related macular degeneration
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Bayer
- 12 Jan 2018 New trial record
- 09 Jan 2018 Results assessing safety, tolerability and systemic exposure published in the British Journal of Clinical Pharmacology